
Ganesh Raghu
Director, Center for Interstitial Lung Diseases (ILD),UW Medicine · University of Washington School of Medicine
Credentials: · · · · · · · ·
History
PresentCenter for Interstitial Lung Diseases (ILD) · University of Washington School of Medicine
PresentScleroderma Clinic · University of Washington School of Medicine

- 1977–1978
- 1974–1977
Bangalore Univ. Medical College Hospital Residency
- 1973–1974
University Hospitals
- 1971–1974
Bowring Hospital and Postgraduate Medical Institute
- 1969–1973
Research
American Journal of Respiratory and Critical Care Medicine · 2011 · First of 34 authors · 5,726 citations
Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis
New England Journal of Medicine · 2014 · 3,674 citations
American Journal of Respiratory and Critical Care Medicine · 2013 · 3,318 citations

73 papers

54 papers

52 papers
- DL
33 papers

33 papers

31 papers

30 papers

30 papers
Grants
- 2013–2018
Treatment of IPF with Laparoscopic Anti-Reflux Surgery
National Heart, Lung, and Blood Institute · UM1
PI · $5M · University of California, San Francisco
- 2005–2012
Clinical Center for an Idiopathic Pulmonary Fibrosis Cl*
National Heart, Lung, and Blood Institute · U10
Contact PI · $963.7K · University of Washington
- 1987–1999
Fibroblast Heterogeneity in Normal and Fibrotic Lungs
National Heart, Lung, and Blood Institute · R01
Contact PI · $1.6M · University of Washington
- 1996–1998
Environmental Risk for Idiopathic Pulmonary Fibrosis
National Institute of Environmental Health Sciences · R03
Contact PI · $72K · University of Washington
Clinical trials
- 2021–2025
Yoga Effect on Quality of Life Study Among Patients with Idiopathic Pulmonary Fibrosis
Principal investigator · Active not recruiting
University of Washington
- 2019–2020
Quality of Life in IPF - Patient and Physician Perceptions
Principal investigator · Completed
University of Washington
- 2013–2017
Treatment of IPF With Laparoscopic Anti-Reflux Surgery
Principal investigator · Completed
University of California, San Francisco
- 2009–2014
Evaluating the Effectiveness of Prednisone, Azathioprine, and N-acetylcysteine in Patients With IPF
Principal investigator · Completed · Phase 3
Duke University


